Skip to content
Search

Latest Stories

Sajid Javid vouches support for “pharmacy first” model of care in England

Health secretary Sajid Javid vouches support for a “pharmacy first” model of care for minor illnesses, to help clear the backlog of NHS care arising due to the Covid-19 pandemic.

Speaking at the National Pharmacy Association’s (NPA) centenary dinner in central London on Wednesday (November 24), Javid said he wanted to “go further” than existing services like the NHS Community Pharmacist Consultation Service, to make it “quicker and easier” for people to access primary care.


He said: “I want to see how much further we can go. That’s one of the reasons why we’re working up plans for a pharmacy first model in England that will direct more patients directly to pharmacies without having to go to see their GPs. This will help us to beat the backlog and make sure that even more people can benefit from (pharmacists’) brilliant advice and care.”

Expressing his commitment to transform every aspect of health and care in the country he said that community pharmacies should be “at the very heart of primary care - not just treating people but preventing people from becoming patients in the first place.”

Custodians of nation’s health

Calling pharmacists, the custodians of the nation’s health and the friendly face of healthcare in our communities, Javid said: “I want to make sure we are making the very best use of your talents, to provide care in a quicker and easier way.”

Javid said that pharmacists have played a “starring role” during the pandemic by providing essential care and advice to people.

He said: “You have played a starring role in this pandemic. You stayed open to get medicines to those who need them; you’ve helped us make lateral flow tests part of people’s everyday routine; and you’ve also put jabs in the arms of people to tackle both cold and flu.”

Talking about his vision for pharmacies and expanding their role he said: “I want to see more pharmacies dealing with healthy people with minor illnesses and being referred to and treated in their community pharmacies.”

Javid also appreciated the Medicines and Healthcare products Regulatory Agency (MHRA) for their work on approving Covid-19 vaccinations.

NPA chair, Andrew Lane also praised the efforts of pharmacies to save lives during the pandemic, adding they are well-positioned to become “the backlog busting centrepiece of the NHS’s recovery from Covid-19.

“We can dramatically improve access to healthcare, and free up well over 20 million GP and hospital appointments.

He, however, voiced concerns over funding cuts for pharmacies, which needs to be “reversed if we are to power our can-do agenda for improving patient care and tackling the NHS backlog.”

The event was attended by over 100 guests, including representatives from patients groups, doctors’ leaders, senior NHS officials and various pharmacy body representatives.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less